ICON PLCICLREarnings & Financial Report
ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation. As of February 2025 had approximately 41,900 employees in 55 countries.
Revenue
$2.0B
Gross Profit
N/A
Operating Profit
$219.6M
Net Profit
$154.2M
Gross Margin
N/A
Operating Margin
11.0%
Net Margin
7.7%
YoY Growth
-4.3%
EPS
$1.90
ICON PLC Q1 FY2025 Financial Summary
ICON PLC reported revenue of $2.0B (down 4.3% YoY) for Q1 FY2025, with a net profit of $154.2M (down 17.8% YoY) (7.7% margin).
Key Financial Metrics
| Total Revenue | $2.0B |
|---|---|
| Net Profit | $154.2M |
| Gross Margin | N/A |
| Operating Margin | 11.0% |
| Report Period | Q1 FY2025 |
Revenue Breakdown
ICON PLC Q1 FY2025 revenue of $2.0B breaks down across 4 segments, led by Other Customers at $721.6M (36.1% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Other Customers | $721.6M | 36.1% |
| Clients15 | $498.5M | 24.9% |
| Clients1125 | $475.9M | 23.8% |
| Clients610 | $305.4M | 15.3% |
ICON PLC Revenue by Segment — Quarterly Trend
ICON PLC revenue by segment across the last 4 reported quarters, showing how each business line (such as Other Customers and Clients15) has evolved quarter over quarter.
| Segment | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 |
|---|---|---|---|---|
| Other Customers | $681.3M | $693.6M | $721.6M | $752.3M |
| Clients15 | $503.3M | $503.6M | $498.5M | $502.6M |
| Clients1125 | $549.4M | $522.2M | $475.9M | $453.2M |
| Clients610 | $308.8M | $298.0M | $305.4M | $321.9M |
ICON PLC Quarterly Revenue & Net Profit History
ICON PLC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2025 | $2.0B | +0.6% | $2.4M | 0.1% |
| Q2 FY2025 | $2.0B | -4.8% | $183.0M | 9.1% |
| Q1 FY2025 | $2.0B | -4.3% | $154.2M | 7.7% |
| Q3 FY2024 | $2.0B | -1.2% | $197.1M | 9.7% |
| Q2 FY2024 | $2.1B | +4.9% | $146.9M | 6.9% |
| Q1 FY2024 | $2.1B | +5.7% | $187.4M | 9.0% |
| Q3 FY2023 | $2.1B | +5.8% | $163.7M | 8.0% |
| Q2 FY2023 | $2.0B | +4.4% | $115.6M | 5.7% |
Income Statement
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.02B | $2.06B | $2.09B | $2.12B | $2.03B | $2.00B | $2.02B | $2.04B |
| YoY Growth | 4.4% | 5.8% | 5.7% | 4.9% | -1.2% | -4.3% | -4.8% | 0.6% |
Balance Sheet
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $17.11B | $17.03B | $17.05B | $16.97B | $17.21B | $16.72B | $16.60B | $16.51B |
| Liabilities | $8.31B | $8.07B | $7.62B | $7.38B | $7.44B | $7.22B | $7.05B | $7.17B |
| Equity | $8.80B | $8.96B | $9.43B | $9.59B | $9.77B | $9.50B | $9.56B | $9.33B |
Cash Flow
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $203.9M | $341.5M | $327.1M | $218.6M | $402.7M | $268.2M | $146.2M | $387.6M |